Cahill Ronan A, Redmond H Paul
Department of General Surgery, Cork University Hospital, Wilton, Cork, Ireland.
World J Gastroenterol. 2008 Aug 21;14(31):4861-6. doi: 10.3748/wjg.14.4861.
Peritoneal adhesions are a near inevitable occurrence after laparotomy and a major cause of both patient and physician misery. To date, clinical attempts at their amelioration have concentrated on manipulating the physical factors that affect their development despite a wealth of experimental data elucidating the molecular mechanisms that underlie their initiation, development and maturation. However, the advent of targeted, specific anti-cytokine agents as directed therapy for inflammatory and neoplastic conditions raises the prospect of a new era for anti-adhesion strategies. To harness this potential will require considerable cross-disciplinary collaboration and that surgeon-scientists propel themselves to the forefront of this emerging field.
剖腹手术后,腹膜粘连几乎不可避免,是导致患者和医生痛苦的主要原因。迄今为止,尽管有大量实验数据阐明了腹膜粘连起始、发展和成熟的分子机制,但临床改善腹膜粘连的尝试主要集中在控制影响其发展的物理因素上。然而,针对炎症和肿瘤疾病的靶向特异性抗细胞因子药物的出现,为抗粘连策略带来了新时代的前景。要利用这一潜力,需要大量跨学科合作,外科医生科学家需站在这一新兴领域的前沿。